Watch now to see how RELISTOR targets mu-opioid receptors
If your patients are taking opioids for chronic pain, they might be experiencing Painstipation, the constipation caused by opioids. This is more commonly referred to as opioid-induced constipation (OIC).1
Help provide reliable, rapid relief with RELISTOR—the only PAMORA* that is not metabolized via the CYP3A4 pathway.1,2
PAMORA=peripherally acting mu-opioid receptor antagonist. *Approved for OIC.
Please click here for full Prescribing Information for RELISTOR tablets and RELISTOR injection.
REL.0087.USA.18
Thank you for visiting www.RELISTOR.com. By clicking OK you will be taken to a website or sites to which our Privacy Policy and other rules do not apply. Salix Pharmaceuticals does not possess editorial control over the content of the information provided in such website(s) and therefore does not warrant their accuracy and completeness. You are solely responsible for interactions with such website(s).